Skip to main content

Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah's Witness patient.

Annals of hematology

Authors: Sebastian Schlaweck, Peter Brossart, Annkristin Heine

PMID: 33438048

Participating cluster members